Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion type Assertion NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_head.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion description "[Chromosomal translocations and activation of the fibroblast growth factor (FGF) receptor 1 (FGFR1) are a feature of stem cell leukemia-lymphoma syndrome (SCLL), an aggressive malignancy characterized by rapid transformation to acute myeloid leukemia and lymphoblastic lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_provenance.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion evidence source_evidence_literature NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_provenance.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion SIO_000772 21937681 NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_provenance.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion wasDerivedFrom befree-2016 NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_provenance.
- NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_assertion wasGeneratedBy ECO_0000203 NP925529.RAdTIk9U1O-ixa6s9Ct1xBD2_ONj3jRxAfEEHQZ34O4S0130_provenance.